ineffective for patients with high viral loads who are very sick with the disease The ongoing clinical trial, led by French research institute INSERM, was launched on 17 December 2014 at an Ebola treatment centre run by Médecins Sans Frontières (MSF) in Guéckédou, Guinea, where the current outbreak started. Since then the trial has expanded to include patients from Ebola treatment centres in Nzérékoré and Macenta, also in Guinea. Follow details on http://www.msf.org/article/initial-results-experimental-ebola-drug-show-positive-effect-some-patients
Initial results with experimental Ebola drug show positive effect for some patients
24 February 2015, 5:44 pm Written by Micat Liberia
Published in
News Flash
Initial results of a clinical trial of the experimental drug favipiravir suggest that it can reduce mortality among patients with low levels of the Ebola virus in their blood, but is
ineffective for patients with high viral loads who are very sick with the disease The ongoing clinical trial, led by French research institute INSERM, was launched on 17 December 2014 at an Ebola treatment centre run by Médecins Sans Frontières (MSF) in Guéckédou, Guinea, where the current outbreak started. Since then the trial has expanded to include patients from Ebola treatment centres in Nzérékoré and Macenta, also in Guinea. Follow details on http://www.msf.org/article/initial-results-experimental-ebola-drug-show-positive-effect-some-patients